QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
QQQ   423.96 (-0.44%)
AAPL   167.03 (-0.58%)
MSFT   405.71 (-1.49%)
META   502.21 (+1.63%)
GOOGL   156.42 (+0.61%)
AMZN   179.33 (-1.08%)
TSLA   151.18 (-2.75%)
NVDA   848.14 (+0.93%)
AMD   154.95 (+0.60%)
NIO   4.01 (+2.56%)
BABA   68.90 (+0.12%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.71 (-3.11%)
GE   153.81 (-1.19%)
CGC   8.02 (+23.57%)
DIS   113.03 (+0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.20 (-1.68%)
XOM   118.34 (-0.24%)
NASDAQ:XAIR

Beyond Air (XAIR) Stock Price, News & Analysis

$1.16
-0.12 (-9.09%)
(As of 03:15 PM ET)
Today's Range
$1.16
$1.31
50-Day Range
$1.28
$2.15
52-Week Range
$1.16
$6.36
Volume
437,786 shs
Average Volume
298,727 shs
Market Capitalization
$41.94 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$11.25

Beyond Air MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
821.7% Upside
$11.25 Price Target
Short Interest
Bearish
9.71% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.91
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.93) to ($1.57) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.56 out of 5 stars

Medical Sector

274th out of 914 stocks

Surgical & Medical Instruments Industry

32nd out of 94 stocks

XAIR stock logo

About Beyond Air Stock (NASDAQ:XAIR)

Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

XAIR Stock Price History

XAIR Stock News Headlines

Beyond Air, Inc. (NASDAQ:XAIR) Short Interest Update
Henry Kissinger’s chilling AI warning
Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.
Beyond Air Prices Direct Offering Of $16 Mln Of Shares, Warrants
Will Renewed Nvidia Excitement Lift the Entire Market?
Henry Kissinger’s chilling AI warning
Not long before his death in 2023, Henry Kissinger wrote about a "world of potentially total destructiveness and substantial uncertainty." He was talking about the advent of generative artificial intelligence (AI)... And how we are woefully unprepared for the consequences this technology could bring.
Beyond Air (XAIR) Earnings Dates & Reports
Recap: Beyond Air Q3 Earnings
A Preview Of Beyond Air's Earnings
Beyond Air Independent Director Acquires 102% More Stock
Beyond Air Inc XAIR
See More Headlines
Receive XAIR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Beyond Air and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/12/2024
Today
4/18/2024
Next Earnings (Estimated)
6/27/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:XAIR
Fax
N/A
Employees
98
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$11.25
High Stock Price Target
$15.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+779.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-55,820,000.00
Pretax Margin
-10,288.97%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.40 per share

Miscellaneous

Free Float
29,192,000
Market Cap
$46.13 million
Optionable
Optionable
Beta
-0.18
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Executives


XAIR Stock Analysis - Frequently Asked Questions

Should I buy or sell Beyond Air stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Beyond Air in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" XAIR shares.
View XAIR analyst ratings
or view top-rated stocks.

What is Beyond Air's stock price target for 2024?

3 brokerages have issued 1 year price targets for Beyond Air's shares. Their XAIR share price targets range from $10.00 to $15.00. On average, they anticipate the company's share price to reach $11.25 in the next twelve months. This suggests a possible upside of 821.7% from the stock's current price.
View analysts price targets for XAIR
or view top-rated stocks among Wall Street analysts.

How have XAIR shares performed in 2024?

Beyond Air's stock was trading at $1.96 at the start of the year. Since then, XAIR shares have decreased by 37.7% and is now trading at $1.2206.
View the best growth stocks for 2024 here
.

Are investors shorting Beyond Air?

Beyond Air saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 3,500,000 shares, an increase of 23.2% from the March 15th total of 2,840,000 shares. Based on an average daily volume of 299,900 shares, the short-interest ratio is currently 11.7 days.
View Beyond Air's Short Interest
.

When is Beyond Air's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 27th 2024.
View our XAIR earnings forecast
.

How were Beyond Air's earnings last quarter?

Beyond Air, Inc. (NASDAQ:XAIR) posted its quarterly earnings data on Monday, February, 12th. The company reported ($0.50) earnings per share for the quarter, beating the consensus estimate of ($0.61) by $0.11. The company earned $0.39 million during the quarter, compared to analysts' expectations of $0.49 million. During the same quarter in the prior year, the firm earned ($0.43) earnings per share.

What guidance has Beyond Air issued on next quarter's earnings?

Beyond Air updated its FY 2025 earnings guidance on Tuesday, February, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $12.0 million-$16.0 million.

What other stocks do shareholders of Beyond Air own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Beyond Air investors own include OPKO Health (OPK), NVIDIA (NVDA), Pfizer (PFE), Axsome Therapeutics (AXSM), BioCryst Pharmaceuticals (BCRX), Enphase Energy (ENPH), General Motors (GM), Livongo Health (LVGO), Main Street Capital (MAIN) and Ollie's Bargain Outlet (OLLI).

How do I buy shares of Beyond Air?

Shares of XAIR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:XAIR) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners